The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
Holmström, M O, Martinenaite, E, Ahmad, S M, Met, Ö, Friese, C, Kjær, L, Riley, C H, Thor Straten, P, Svane, I M, Hasselbalch, H C, Andersen, M H
Published in Leukemia (01.02.2018)
Published in Leukemia (01.02.2018)
Get full text
Journal Article
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
Holmström, M O, Hjortsø, M D, Ahmad, S M, Met, Ö, Martinenaite, E, Riley, C, Straten, P, Svane, I M, Hasselbalch, H C, Andersen, M H
Published in Leukemia (01.02.2017)
Published in Leukemia (01.02.2017)
Get full text
Journal Article
The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms
Holmström, M O, Riley, C H, Svane, I M, Hasselbalch, H C, Andersen, M H
Published in Leukemia (01.12.2016)
Published in Leukemia (01.12.2016)
Get full text
Journal Article
The calreticulin
Riley, C H, Kjaer, L, Holmström, M O, thor Straten, P, Friese, C, Ahmad, S M, Hasselbalch, H C, Martinenaite, E, Svane, I M, Andersen, M H, Met, Ö
Published in Leukemia (01.02.2018)
Get full text
Published in Leukemia (01.02.2018)
Journal Article
The Danish National Multiple Myeloma Registry
Gimsing, Peter, Holmström, Morten O, Klausen, Tobias Wirenfelt, Andersen, Niels Frost, Gregersen, Henrik, Pedersen, Robert Schou, Plesner, Torben, Pedersen, Per Trøllund, Frederiksen, Mikael, Frølund, Ulf, Helleberg, Carsten, Vangsted, Annette, de Nully Brown, Peter, Abildgaard, Niels
Published in Clinical epidemiology (01.01.2016)
Published in Clinical epidemiology (01.01.2016)
Get full text
Journal Article